Core Viewpoint - Chengdu Olin Biological Technology Co., Ltd. is planning to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy, increase its global visibility, and optimize its capital structure [1][2]. Group 1 - The company is currently discussing the details of the H-share listing with relevant intermediaries, and specific details have not yet been finalized [2]. - The H-share listing process will require approval from the company's board and shareholders, as well as regulatory approvals from the China Securities Regulatory Commission, the Hong Kong Stock Exchange, and the Securities and Futures Commission of Hong Kong [2]. - The company will fulfill its information disclosure obligations in accordance with relevant laws and regulations as the H-share listing progresses [2].

截至6月30日，我武生物股东户数3.46万，较上期减少3.53%；人均流通股13999股，较上期增加3.66%。 2025年1月-6月，我武生物实现营业收入4.84亿元，同比增长12.81%；归母净利润1.77亿元，同比增长 18.61%。 分红方面，我武生物A股上市后累计派现9.13亿元。近三年，累计派现3.17亿元。 机构持仓方面，截止2025年6月30日，我武生物十大流通股东中，招商国证生物医药指数A（161726） 位居第五大流通股东，持股469.01万股，相比上期减少18.80万股。香港中央结算有限公司位居第七大流 通股东，持股410.96万股，相比上期减少49.18万股。创新药（159992）退出十大流通股东之列。 责任编辑：小浪快报 9月24日，我武生物盘中上涨2.03%，截至10:55，报28.65元/股，成交1.14亿元，换手率0.83%，总市值 150.01亿元。 资金流向方面，主力资金净流出379.71万元，特大单买入618.72万元，占比5.42%，卖出1608.09万元， 占比14.10%；大单买入1852.06万元，占比16.23%，卖出1242.39万元，占比10.89%。 我武 ...

Core Viewpoint - The company, Beijing Hotgen Biotech Co., Ltd., is set to hold a half-year performance briefing on October 10, 2025, to discuss its operational results and financial status for the first half of 2025, allowing investors to engage in Q&A sessions [2][3]. Group 1: Meeting Details - The performance briefing will take place on October 10, 2025, from 16:00 to 17:00 [6]. - The meeting will be held at the Shanghai Stock Exchange Roadshow Center and will be conducted in an interactive online format [5][6]. - Investors can submit questions from September 25, 2025, to October 9, 2025, through the Roadshow Center website or via the company's email [7]. Group 2: Company Communication - The company aims to provide a comprehensive understanding of its half-year operational achievements and financial indicators during the briefing [3]. - The company will address common investor concerns and questions during the session [3][5]. - After the meeting, investors can access the main content and details of the briefing through the Roadshow Center [7].

本报讯 （记者王镜茹）9月23日晚间，广州万孚生物技术股份有限公司（以下简称"万孚生物"）发布了 《关于回购公司股份方案暨回购报告书的公告》，公司拟使用自有资金以集中竞价交易方式回购部分公 司股份。 公告显示，基于对公司未来发展前景的信心，为进一步健全公司长效激励机制，充分保证公司业务持续 成长，鼓励价值创造，公司在综合考虑经营情况、业务发展前景、财务状况以及未来盈利能力的基础 上，拟以自有资金回购公司股份并全部用于员工持股计划或股权激励。 根据公告，此次拟回购的股份价格为不超过34.66元/股（含）。回购股份的资金总额为不低于3000万元 （含）且不超过6000万元（含）。公司预计回购股份数量约为86.56万股至173.11万股，约占公司目前总 股本的0.18%至0.37%，具体回购股份数量以回购期满或回购完毕时公司实际回购的股份数量为准。 （编辑 郭之宸） ...

证券日报网讯敷尔佳9月23日发布公告，在公司回答调研者提问时表示，目前公司重组三型人源化胶原 蛋白冻干纤维临床试验的三轮注射已全部完成，项目处于数据清理与总结报告筹备阶段，进展顺利，符 合公司预期。 （文章来源：证券日报） ...

2025 年 09 月 23 日 从基金中报看北交所机构化趋势 -2025H1 北交所公募持仓分析 相关研究 若研究院 证券分析师 刘靖 A0230512070005 liujinq@swsresearch.com 研究支持 目靖华 A0230124070002 lvjh@swsresearch.com 联系人 目靖华 (8621)23297818× lvjh@swsresearch.com 申万宏源研究微信服务 请务必仔细阅读正文之后的各项信息披露与声明 ● 公募增配北交所趋势持续，主动权益公募大幅入市。截至 25H1，公募配置北交所市值达 223.83 亿元,配置比例达 0.37%、环比+0.15pct, 配置系数达 0.59、环比+0.07, 自 24H1 以来,公募连续三个半年度增配北交所。其中，主动权益产品大幅入市, 截至 25H1, 主动权益公募配置北交所比例达 0.46%、环比+0.26pct，配置系数达 0.74、环比+0.24。 分投资类型看, 1) 主动管理视角, 截至 25H1, 主动权益基金合计持仓北交所市值达 112.2 ○ 亿元、相比 24H2 大幅增长+116%。一方面，北证契合 ...

Group 1 - The company, Olin Bio (688319.SH), is planning to issue overseas shares (H-shares) and apply for listing on the Hong Kong Stock Exchange to enhance its international presence and influence [1] - This initiative is part of the company's strategy to deepen its internationalization efforts and optimize its capital structure [1] - The goal of this move is to strengthen the company's overall competitiveness in the market [1]

Core Viewpoint - The company, Olin Bio (688319.SH), is planning to issue overseas shares (H-shares) and apply for listing on the Hong Kong Stock Exchange to enhance its international strategy, increase global visibility and influence, and further optimize its capital structure to strengthen its overall competitiveness [1] Group 1 - The company is currently in discussions with relevant intermediaries regarding the H-share listing [1] - Details of the H-share listing are yet to be determined [1] - The H-share listing plan requires approval from the company's board and shareholders, as well as necessary filings and approvals from relevant government and regulatory bodies [1]

Core Viewpoint - The company is planning to issue overseas shares (H-shares) and apply for listing on the Hong Kong Stock Exchange [1] Group 1 - The company is currently in discussions with relevant intermediaries regarding the H-share listing [1] - Details of the H-share listing have not yet been finalized [1] - The H-share listing process requires approval from the company's board of directors and shareholders, as well as regulatory approvals from the China Securities Regulatory Commission, Hong Kong Stock Exchange, and the Securities and Futures Commission of Hong Kong [1]

Market Overview - The A-share market showed mixed performance with the Shanghai Composite Index closing at 3821.83 points, down by 0.18%, and a trading volume of 1,071.698 billion yuan [1] - The Shenzhen Component Index closed at 13119.82 points, down by 0.29%, with a trading volume of 1,422.684 billion yuan [1] - The ChiNext Index closed at 3114.55 points, up by 0.21%, with a trading volume of 665.817 billion yuan [1] Sector Performance - The top-performing sectors included port shipping, banking, and semiconductors, with port shipping gaining 1.43% and a total trading volume of 22,919.9 million hands [2] - The banking sector increased by 1.28%, with a total trading volume of 60,768.6 million hands [2] - The sectors that experienced the largest declines were tourism and hotels, medical services, and small metals, with tourism and hotels dropping by 5.28% [2] Detailed Sector Analysis - Port shipping sector had a net inflow of 2.79 billion yuan, with 28 stocks rising and 7 falling [2] - The banking sector saw a net inflow of 61.08 billion yuan, with 40 stocks rising and only 1 falling [2] - In contrast, the tourism and hotel sector had a net outflow of 16.76 billion yuan, with no stocks rising and 34 stocks declining [2]